Rockefeller Capital Management L.P. Vbi Vaccines Inc Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.27 - $2.47 $2,540 - $4,940	-2,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$2.61 - $4.17 $5,220 - $8,340	2,000 New	2,000 $6,000
Q1 2021 May 11, 2021	SELL	$2.91 - $4.32 $727 - $1,080	-250 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $537 - $875	250 New	250 $0

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.